Molecular Testing Solutions Newsletter

 

Rapid monitoring of SARS-CoV-2 variants in the United States

Early indications of emerging variants using PCR-based technology

Learn more about the collaboration with Thermo Fisher Scientific, the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind to develop a new genotyping method designed to accelerate the identification of SARS-CoV-2 variants as they emerge. 

Featured speakers:

  • Jeremy Davis-Turak, PhD, Chief Technology Officer of Rosalind
  • Manoj Ghandhi, MD, PhD, Sr. Director of Medical and Scientific Affairs, Genetic Testing Solutions, Thermo Fisher Scientific

* Required field

*
*
*
*
*
*